JAcques rossignol

Partner and Co-Founder of TechLife Capital

Jacques Rossignol is a Managing Partner and Co-Founder of TechLife Capital. He has been a private equity growth investor for more than 20 years, has covered the healthcare industry since 2004 and the technology industry since 1998. Aside from Flash Therapeutics (Flash BioSolutions), he is currently the President of the Supervisory Board of XPath Groupe (cancer diagnosis services), of Mitem Pharma (pharmaceutical laboratory for drugs of major therapeutic interest), and of Evolutis (orthopedic implants), a member of the Supervisory Board of Quinten (data science expert of AI-based solutions for pharma and healthcare services) and used to be a Member of the Supervisory Board of Synerlab (a pharmaceutical CDMO). Before TechLife Capital, he was head of France at Alpha Private Equity, Managing Partner at 21 Invest and Director at Ekkio. He started his career in Investment Banking at BNP Paribas and Goldman Sachs (Paris, London). He is a graduate from Ecole Polytechnique and holds an MBA degree from the Harvard Business School.